News
TOMI Environmental Solutions, Inc. ® ("TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and ...
The International (CCHR), a leading mental health industry watchdog, has released a damning report detailing how ...
In the dusty outskirts of Seminole, Texas - just past the cotton fields and under the relentless spring sun - Peter Hildebrand stands outside a gas station, his eyes rimmed red and voice cracking.
As per Vantage Market Research, the Global Pharmaceutical Sterility Testing Market has been significantly growing over the ...
Dual Trials Accelerate VELDONA® Toward Rare Disease Market EntryBridging Strategy Aims to Fast-Track U.S. Regulatory Approvals SAN DIEGO, CALIFORNIA / ACCESS Newswire / April 14, 2025 / Ainos, Inc.
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced today a settlement and license agreement with ...
I called RFK Jr. an "extinction-level" threat to US biomedical science and public health. That extinction is under way.
Background: Obesity is a complex, chronic, stigmatized disease whereby abnormal or excess body fat may impair health or increase the risk of medical complications, and can reduce quality of life and ...
Bristol Myers Squibb today announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult patients with symptomatic New York Heart Association (NYHA) class II-III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results